In vivo laboratory models for RIIH that replicate the insulin route of administration, injection frequency, and formulation duration of action in the clinical setting reveal a diminished nerve cell transcriptional activation in brain metabolic structures, an outcome that infers neurological desensitization to hypoglycemia [46,47]. This evidence concerns the gene INS and Hypoglycemia.